Neogen(NASDAQ) NEOG

Neogen Corporation helps companies test food for dangerous bacteria. It also makes tools and medicines to keep farm animals healthy. These products help prevent illness and support safe farming.

What Neogen Brings to the Table

• Food Safety: Diagnostic kits that detect pathogens, allergens, and toxins; generated $163.2 million in revenue during the three months ended Aug. 31, 2026.
• Animal Safety: Veterinary tools, vaccines, and pest control products; generated $59.6 million in revenue during the three months ended Aug. 31, 2026.
• Sanitation Tests: Rapid tools that check surfaces for living cells to ensure proper cleaning.
• Genomics Services: Genetic testing for livestock and pets to help with breeding and health tracking.

Strategic Moves and New Directions

• Relocated manufacturing of sample collection products from 3M to a Neogen facility during fiscal year 2025.
• Entered a definitive agreement on March 2, 2026, to sell the Genomics business to Zoetis Inc.
• Completed the sale of the Cleaners and Disinfectants business during fiscal year 2026.
• Initiated a growth strategy in the first quarter of fiscal year 2027 focused on commercial excellence, innovation, and operational efficiency.

Global Reach and Market Focus

Neogen uses a global distribution network to reach food processors, grain operations, and pharmaceutical manufacturers. The company focuses on operational efficiency and a rigorous sales model to maintain its position in the food safety market.

The Quarter in Numbers

• Total revenues were $222.8 million for the three months ended Aug. 31, 2026, up 6.5% year over year.
• Net loss was $11.9 million for the three months ended Aug. 31, 2026, compared to a net income of $36.3 million in the prior year.
• Cash and cash equivalents reached $172.0 million as of Aug. 31, 2026.
• Operating loss was $1.8 million for the three months ended Aug. 31, 2026, down 88.8% year over year.
• Capital expenditures are estimated at approximately $40.0 million for fiscal year 2027.

Bottom Line

Neogen is streamlining its operations by divesting noncore units and integrating major acquisitions. This transition aims to build a more efficient business focused on core diagnostic and animal health technologies.